Brain Changes During Blood Cancer Immunotherapy
Part of Blood & lymphatic, Cancer, Heart & circulation, Immune system & allergy clinical trials.
This study looks at whether treatments that boost the immune system to fight blood cancers might affect thinking and memory. Researchers will track cognitive (thinking and memory) changes in patients receiving cell-based or antibody-based immunotherapies to understand any side effects and help future patients.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are at least 18 years old
- You speak and read Danish fluently
- You are willing to give informed consent to participate
- Your blood cancer has not spread to your brain or central nervous system
- You do not have cognitive (thinking or memory) problems from a pre-existing psychiatric or neurological condition
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how thinking and memory may change in children and young adults after a new cancer diagnosis, especially around chemotherapy. It may help doctors better understand and track brain-related side effects early.
This trial studies how radiation therapy affects thinking and memory in adults with certain brain tumors. It may help doctors understand which patients are more likely to have cognitive side effects and how to measure them over time.
This study looks at how whole-brain radiation affects thinking, memory, and other brain function in people with blood cancers that involve the brain. It may help doctors understand what to expect and which supportive treatments or monitoring could be useful.
This study tests whether special brain exercises can help protect thinking and memory skills during CAR-T cell therapy—a newer cancer treatment for certain blood cancers. Researchers want to see if training your brain during treatment reduces side effects on memory and mental function.
This study examines whether a new type of cancer medication affects thinking, memory, and focus in people with chronic myeloid leukemia (CML) or chronic lymphocytic leukemia (CLL). Researchers will compare people starting this medication with healthy volunteers to understand any changes.
This study looks at whether chemotherapy for blood cancers like leukemia and lymphoma can affect thinking, memory, or concentration. It compares patients to a close family member or friend to see if any changes are related to the treatment.
Hear when a new Malignant Lymphoma - Lymphoplasmacytic trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.